133 related articles for article (PubMed ID: 38888469)
81. [Surgical therapy of hepatic fibrolamellar carcinoma].
Meriggi F; Forni E
Ann Ital Chir; 2007; 78(1):53-8. PubMed ID: 17518332
[TBL] [Abstract][Full Text] [Related]
82. Novel somatic mutations in the catalytic subunit of the protein kinase A as a cause of adrenal Cushing's syndrome: a European multicentric study.
Di Dalmazi G; Kisker C; Calebiro D; Mannelli M; Canu L; Arnaldi G; Quinkler M; Rayes N; Tabarin A; Laure Jullié M; Mantero F; Rubin B; Waldmann J; Bartsch DK; Pasquali R; Lohse M; Allolio B; Fassnacht M; Beuschlein F; Reincke M
J Clin Endocrinol Metab; 2014 Oct; 99(10):E2093-100. PubMed ID: 25057884
[TBL] [Abstract][Full Text] [Related]
83. Progression after Immunotherapy for Fibrolamellar Carcinoma.
Bauer U; Mogler C; Braren RF; Algül H; Schmid RM; Ehmer U
Visc Med; 2019 Mar; 35(1):39-42. PubMed ID: 31312648
[TBL] [Abstract][Full Text] [Related]
84. Hepatocellular Carcinoma, Fibrolamellar Variant: Diagnostic Pathologic Criteria and Molecular Pathology Update. A Primer.
Sergi CM
Diagnostics (Basel); 2015 Dec; 6(1):. PubMed ID: 26838800
[TBL] [Abstract][Full Text] [Related]
85. Transcriptional profiling of pure fibrolamellar hepatocellular carcinoma reveals an endocrine signature.
Malouf GG; Job S; Paradis V; Fabre M; Brugières L; Saintigny P; Vescovo L; Belghiti J; Branchereau S; Faivre S; de Reyniès A; Raymond E
Hepatology; 2014 Jun; 59(6):2228-37. PubMed ID: 24443104
[TBL] [Abstract][Full Text] [Related]
86. Alternate protein kinase A activity identifies a unique population of stromal cells in adult bone.
Tsang KM; Starost MF; Nesterova M; Boikos SA; Watkins T; Almeida MQ; Harran M; Li A; Collins MT; Cheadle C; Mertz EL; Leikin S; Kirschner LS; Robey P; Stratakis CA
Proc Natl Acad Sci U S A; 2010 May; 107(19):8683-8. PubMed ID: 20421483
[TBL] [Abstract][Full Text] [Related]
87. Identification and characterization of novel mutations in the human gene encoding the catalytic subunit Calpha of protein kinase A (PKA).
Søberg K; Larsen AC; Diskar M; Backe PH; Bjørås M; Jahnsen T; Laerdahl JK; Rognes T; Herberg FW; Skålhegg BS
PLoS One; 2012; 7(4):e34838. PubMed ID: 22514673
[TBL] [Abstract][Full Text] [Related]
88. PKA Cβ: a forgotten catalytic subunit of cAMP-dependent protein kinase opens new windows for PKA signaling and disease pathologies.
Taylor SS; Wallbott M; Machal EMF; Søberg K; Ahmed F; Bruystens J; Vu L; Baker B; Wu J; Raimondi F; Ongeri EM; Herberg FW; Skålhegg BS
Biochem J; 2021 Jun; 478(11):2101-2119. PubMed ID: 34115095
[TBL] [Abstract][Full Text] [Related]
89. Differential expression of the protein kinase A subunits in normal adrenal glands and adrenocortical adenomas.
Weigand I; Ronchi CL; Rizk-Rabin M; Dalmazi GD; Wild V; Bathon K; Rubin B; Calebiro D; Beuschlein F; Bertherat J; Fassnacht M; Sbiera S
Sci Rep; 2017 Mar; 7(1):49. PubMed ID: 28250426
[TBL] [Abstract][Full Text] [Related]
90. Protein kinase A catalytic subunit isoform PRKACA; History, function and physiology.
Turnham RE; Scott JD
Gene; 2016 Feb; 577(2):101-8. PubMed ID: 26687711
[TBL] [Abstract][Full Text] [Related]
91. The prognosis of fibrolamellar carcinoma versus conventional hepatocellular carcinoma: a study based on propensity score matching.
Qiu S; Chen R; Hu J; Han T
Scand J Gastroenterol; 2023; 58(11):1351-1358. PubMed ID: 37353942
[TBL] [Abstract][Full Text] [Related]
92. Somatic mutations of the catalytic subunit of cyclic AMP-dependent protein kinase (PRKACA) gene in Japanese patients with several adrenal adenomas secreting cortisol [Rapid Communication].
Nakajima Y; Okamura T; Gohko T; Satoh T; Hashimoto K; Shibusawa N; Ozawa A; Ishii S; Tomaru T; Horiguchi K; Okada S; Takata D; Rokutanda N; Horiguchi J; Tsushima Y; Oyama T; Takeyoshi I; Yamada M
Endocr J; 2014; 61(8):825-32. PubMed ID: 25069672
[TBL] [Abstract][Full Text] [Related]
93. Clinical Outcomes in Fibrolamellar Hepatocellular Carcinoma Treated with Immune Checkpoint Inhibitors.
Chen KY; Popovic A; Hsiehchen D; Baretti M; Griffith P; Bista R; Baghdadi A; Kamel IR; Simon SM; Migler RD; Yarchoan M
Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358766
[TBL] [Abstract][Full Text] [Related]
94. Prognosis of Fibrolamellar Carcinoma Compared to Non-cirrhotic Conventional Hepatocellular Carcinoma.
Yamashita S; Vauthey JN; Kaseb AO; Aloia TA; Conrad C; Hassan MM; Passot G; Raghav KP; Shama MA; Chun YS
J Gastrointest Surg; 2016 Oct; 20(10):1725-31. PubMed ID: 27456016
[TBL] [Abstract][Full Text] [Related]
95. Fibrolamellar Hepatocellular Carcinoma: A Population-Based Observational Study.
Ramai D; Ofosu A; Lai JK; Gao ZH; Adler DG
Dig Dis Sci; 2021 Jan; 66(1):308-314. PubMed ID: 32052215
[TBL] [Abstract][Full Text] [Related]
96. Treatment and prognosis of patients with fibrolamellar hepatocellular carcinoma: a national perspective.
Mayo SC; Mavros MN; Nathan H; Cosgrove D; Herman JM; Kamel I; Anders RA; Pawlik TM
J Am Coll Surg; 2014 Feb; 218(2):196-205. PubMed ID: 24315886
[TBL] [Abstract][Full Text] [Related]
97. PRKACA mutations in cortisol-producing adenomas and adrenal hyperplasia: a single-center study of 60 cases.
Thiel A; Reis AC; Haase M; Goh G; Schott M; Willenberg HS; Scholl UI
Eur J Endocrinol; 2015 Jun; 172(6):677-85. PubMed ID: 25750087
[TBL] [Abstract][Full Text] [Related]
98. PRKACA Somatic Mutations Are Rare Findings in Aldosterone-Producing Adenomas.
Rhayem Y; Perez-Rivas LG; Dietz A; Bathon K; Gebhard C; Riester A; Mauracher B; Gomez-Sanchez C; Eisenhofer G; Schwarzmayr T; Calebiro D; Strom TM; Reincke M; Beuschlein F
J Clin Endocrinol Metab; 2016 Aug; 101(8):3010-7. PubMed ID: 27270477
[TBL] [Abstract][Full Text] [Related]
99. Reversing immunosuppression in the tumor microenvironment of fibrolamellar carcinoma via PD-1 and IL-10 blockade.
Daniel SK; Sullivan KM; Dickerson LK; van den Bijgaart RJE; Utria AF; Labadie KP; Kenerson HL; Jiang X; Smythe KS; Campbell JS; Pierce RH; Kim TS; Riehle KJ; Yeung RS; Carter JA; Barry KC; Pillarisetty VG
Sci Rep; 2024 Mar; 14(1):5109. PubMed ID: 38429349
[TBL] [Abstract][Full Text] [Related]
100. Genes encoding catalytic subunits of protein kinase A and risk of spina bifida.
Zhu H; Lu W; Laurent C; Shaw GM; Lammer EJ; Finnell RH
Birth Defects Res A Clin Mol Teratol; 2005 Sep; 73(9):591-6. PubMed ID: 16080189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
